[1]
D. Kasuma, N. N. Soeroso, S. P. Tarigan, and E. Syahruddin, “Survival Rate in Lung Adenocarcinoma with Mutation of the EGFR Gene with Tyrosine Kinase Inhibitor Treatment”, Open Access Maced J Med Sci, vol. 10, no. T7, pp. 199–204, Apr. 2022.